Abstract
Angiotensin II (AngII) exerts a critical role in thoracic aortic aneurysm (TAA) formation via AngII type 1a receptor (AT1aR). However, the principal cell type mediating this process remains unclear. Our previous study demonstrated that S100A4-lineage cells are present in the aortic wall and involved in AngII-induced vascular remodeling. In the present study, we investigated whether S100A4-lineage cells contribute to AngII-mediated TAA formation through AT1aR. Proteomic, bulk RNA sequencing, and single-cell RNA sequencing data were analyzed to assess changes in S100A4 abundance in response to AngII infusion. Lineage tracing was performed to track S100A4-lineage cells during AngII-mediated TAA formation. Either saline or AngII was infused in mice with genetic deletion of AT1aR in S100A4-lineage cells and their wild-type littermates. AngII infusion increased S100A4 protein and mRNA abundance significantly in the ascending aorta, particularly within smooth muscle cells and fibroblasts. Lineage tracing revealed that S100A4-positive cells were localized to the media and adventitia under basal conditions. Following AngII infusion, S100A4-lineage cells expanded markedly throughout the entire aortic wall and comprised a heterogeneous population including smooth muscle cells and fibroblasts. Deletion of AT1aR in S100A4-lineage cells partially reduced AngII-induced TAA formation. In conclusion, S100A4-lineage cells modestly contribute to AngII-mediated TAA development through AT1aR in mice.
| Original language | English |
|---|---|
| Article number | e0348111 |
| Journal | PLoS ONE |
| Volume | 21 |
| Issue number | 5 May |
| DOIs | |
| State | Published - May 2026 |
Bibliographical note
Publisher Copyright:© 2026 Ito et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding
Funding: The studies reported in this manuscript were supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (R35HL155649, R01HL133723 [AD]), the American Heart Association (23MERIT1036341 [AD], 24CDA1268148 [HS]), the Leducq Foundation for the Networks of Excellence Program (Cellular and Molecular Drivers of Acute Aortic Dissections; 22CVD03 [AD]), and EXcellence Program for Engaging Research Talent - Japan (EXPERT-J, JPMJEX2506 [HS]). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
| Funders | Funder number |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | |
| American the American Heart Association | 23MERIT1036341, 24CDA1268148 |
| National Institutes of Health (NIH) | R01HL133723, R35HL155649 |
| Leducq Foundation for the Networks of Excellence Program | 22CVD03 |
| EXcellence Program for Engaging Research Talent | JPMJEX2506 |
ASJC Scopus subject areas
- General
Fingerprint
Dive into the research topics of 'S100A4-lineage cells contribute modestly to angiotensin II-mediated thoracic aortic aneurysms through angiotensin II type 1a receptor in mice'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver